Literature DB >> 12414519

Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice.

Anita Narula1, Signe Kilen, Eva Ma, Jessica Kroeger, Erwin Goldberg, Teresa K Woodruff.   

Abstract

Members of the transforming growth factor-beta (TGF-beta) superfamily play a variety of important roles in testicular development and function. The tumor suppressor gene, Smad4, is a common mediator of TGF-beta, activin, and bone morphogenetic protein-mediated signaling pathways. To investigate the role of the Smad4 gene during testicular development and function, transgenic mice were generated using a Flag-tagged Smad4 gene driven by 180-bp fragment of the Mullerian inhibiting substance upstream promoter sequence. Three Smad4 transgenic founders (A, B, and G) were detected by Southern blot analysis; line B showed the highest expression of the Smad4 transgene and was further studied. The fertility in F1 generation (B) and F2 generation (BB) of the Smad4 transgenic mice was not impaired. However, in the F3 generation (B2x) all animals were impacted by the overexpression of the Smad4 transgene and two kinds of phenotypes were observed. In one group animals were completely infertile, while in the other group animals were fertile and sired the normal number of pups/litter. These groups are designated as infertile and fertile in the text. Histological evaluation of the testes from the infertile group showed variable degrees of Leydig cell hyperplasia, apoptosis of germ cells, spermatogenic arrest, seminiferous tubule degeneration, and infertility. In the fertile group, there was no apparent change in the histology of the testis except for a slight increase in the number of Leydig cells. Serum follicle-stimulating hormone levels in the adult animals of both groups of Smad4 transgenic male mice were not significantly different from normal littermates; however, testosterone levels in both groups were significantly (P < 0.05) increased. These results suggest that overexpression of Smad4 leads to testicular abnormalities and infertility supporting the hypothesis that the TGF-beta signaling pathways are carefully orchestrated during testicular development. In the absence of normal levels of Smad4 testicular function is compromised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414519      PMCID: PMC1850786          DOI: 10.1016/S0002-9440(10)64449-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

Review 1.  Newer agents for hormonal contraception in the male.

Authors:  J K Amory; W J Bremner
Journal:  Trends Endocrinol Metab       Date:  2000-03       Impact factor: 12.015

2.  Developmentally regulated expression of Smad3, Smad4, Smad6, and Smad7 involved in TGF-beta signaling.

Authors:  K Luukko; A Ylikorkala; T P Mäkelä
Journal:  Mech Dev       Date:  2001-03       Impact factor: 1.882

Review 3.  Signaling of transforming growth factor-beta family members through Smad proteins.

Authors:  S Itoh; F Itoh; M J Goumans; P Ten Dijke
Journal:  Eur J Biochem       Date:  2000-12

4.  Sertoli cell-specific rescue of fertility, but not testicular pathology, in Dax1 (Ahch)-deficient male mice.

Authors:  B Jeffs; M Ito; R N Yu; F A Martinson; Z J Wang; L T Doglio; J L Jameson
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

5.  Transforming growth factor-beta receptor types I and II in cultured porcine leydig cells: expression and hormonal regulation.

Authors:  I Goddard; M Bouras; M Keramidas; J C Hendrick; J J Feige; M Benahmed
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

6.  A novel SMAD4 gene mutation in seminoma germ cell tumors.

Authors:  M Bouras; E Tabone; J Bertholon; P Sommer; R Bouvier; J P Droz; M Benahmed
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

Review 7.  Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis.

Authors:  N Dünker; K Krieglstein
Journal:  Eur J Biochem       Date:  2000-12

Review 8.  Studying TGF-beta superfamily signaling by knockouts and knockins.

Authors:  H Chang; A L Lau; M M Matzuk
Journal:  Mol Cell Endocrinol       Date:  2001-06-30       Impact factor: 4.102

Review 9.  Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.

Authors:  J Teixeira; S Maheswaran; P K Donahoe
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

10.  Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis.

Authors:  M M Matzuk; M J Finegold; Y Mishina; A Bradley; R R Behringer
Journal:  Mol Endocrinol       Date:  1995-10
View more
  3 in total

1.  Novel Targets for the Transcription Factors MEF2 in MA-10 Leydig Cells.

Authors:  Mickaël Di-Luoffo; Caroline Daems; Francis Bergeron; Jacques J Tremblay
Journal:  Biol Reprod       Date:  2015-05-27       Impact factor: 4.285

2.  Expression of the TGF-beta1 system in human testicular pathologies.

Authors:  Candela R Gonzalez; María E Matzkin; Mónica B Frungieri; Claudio Terradas; Roberto Ponzio; Elisa Puigdomenech; Oscar Levalle; Ricardo S Calandra; Silvia I Gonzalez-Calvar
Journal:  Reprod Biol Endocrinol       Date:  2010-12-02       Impact factor: 5.211

3.  Increased expression of dermatopontin and its implications for testicular dysfunction in mice.

Authors:  Jun Cai; Weijia Liu; Jie Hao; Maoxin Chen; Gang Li
Journal:  Mol Med Rep       Date:  2016-02-05       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.